Thirty-four asthmatics with a persistent increase in symptoms for at least two weeks and an increase of sputum eosinophils of 4 % or more were randomized in a double-blind fashion to one of three groups that received daily treatment with 100 mg salmeterol , 1 mg BDP or placebo in divided doses using identical pressurized inhalers .
